ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 108 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,526,420 | +23.5% | 1,587,429 | +19.7% | 1.31% | +42.4% |
| Q2 2023 | $26,347,620 | +23.6% | 1,326,000 | +6.6% | 0.92% | +29.9% |
| Q1 2023 | $21,316,572 | -28.7% | 1,244,400 | -18.5% | 0.71% | +9.4% |
| Q4 2022 | $29,885,093 | +989.9% | 1,527,087 | +2954.2% | 0.65% | +627.0% |
| Q4 2020 | $2,742,000 | +301.5% | 50,000 | +66.7% | 0.09% | -79.3% |
| Q4 2019 | $683,000 | – | 30,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |